Germany Switzerland United Kingdom United States of America Worldwide
The Boehringer Ingelheim Fonds awards MD fellowships to outstanding medical students who are prepared to interrupt their studies for at least 10 months and change institution and city to conduct an experimental research project in basic biomedical research. Applications may be submitted at any time, but must reach the foundation at least three months prior to the planned change of location and proposed commencement of the MD fellowship. The entire application - including the project proposal - must be written in English and by the applicants themselves.
Our Guiding Principles
Science is our passion.
The Boehringer Ingelheim Fonds (BIF) is a public foundation - an independent, non-profit organization for the exclusive and direct promotion of basic research in biomedicine. We support up-and-coming junior scientists whose research projects experimentally elucidate the basic phenomena of human life, and organize two International Titisee Conferences per year. We are convinced that great scientific ideas and developments need a stimulating context, freedom and a sound financial fundament. At BIF, we do our best to provide all these for our fellows in our programmes.
Opportunity is About:
Candidates should be from:
Description of Ideal Candidate:
Who can apply for an MD fellowship?
The Boehringer Ingelheim Fonds awards MD fellowships to medical students who wish to pursue an experimentally demanding and hypothesis-driven research project in basic biomedical research in a leading laboratory.
Applicants must study medicine in Germany, put their studies on hold and change their working place (institution and city) for the entire duration of the MD fellowship, i.e. for an uninterrupted period of at least 10 months. Their research stay should take place before the third part of the medical examination (“Dritter Abschnitt der Ärztlichen Prüfung”).
Applicants are eligible if they gained good or very good marks in the first section of the medical examination (“Erster Abschnitt der Ärztlichen Prüfung”) and during their subsequent studies.
Applications must be submitted within 8 years after the University entrance qualification or high school-leaving exam (e.g. “Abitur”) and reach the Boehringer Ingelheim Fonds at least three months before the planned change of location.
We do not support
- clinical studies;
- applied research, such as biotechnological and pharmaceutical (e.g. drug, diagnostic) development and studies on the course of diseases or the treatment of symptoms;
- botanical and prokaryotic investigations unless they are of general biological importance.
Furthermore, the MD fellowships cannot be used to supplement inadequate funding from other institutions or earned incomes, to bridge temporary financial difficulties or to complete investigations already sponsored by other sources or institutions.
Deadline: The application period is open for one or more cycles a year
Cost/funding for participants:
Conditions for MD Fellowships
The Boehringer Ingelheim Fonds must be notified if an application is submitted to any other research-sponsoring institution. Should an applicant take up an award from another institution prior to the decision of the Boehringer Ingelheim Fonds, the application to the Boehringer Ingelheim Fonds is considered withdrawn, and the foundation must be notified immediately.
Please note that only written notification is legally binding and that the decisions of the Boehringer Ingelheim Fonds are incontestable.
The fellowship expires if not taken up within 6 months of notification.
On accepting the MD fellowship, the fellowship holder agrees to the following conditions:
The Boehringer Ingelheim Fonds does not intervene in the work of fellows who, in turn, are obligated to make proper use of the allocated funds and to adhere to the rules of good scientific practice. Each fellow must devote his/her whole energy to his/her particular research project. In the laboratory, fellows should only be assigned to tasks directly connected to their research projects.
If a fellow decides to change the topic of his/her research project or the laboratory, he/she must inform the Boehringer Ingelheim Fonds without delay. In the event of the project being successfully completed prior to expiry of the fellowship, payment will be discontinued.
MD fellowships are granted for 10–12 months, an extension of up to 6 months is possible. The basic monthly stipend amounts to 1000 euros in countries of the European Monetary System. In Switzerland, the United Kingdom and the USA, a further 450 euros are added as a country-related premium. Depending on the cost of living, all other countries are grouped into one of these categories. In most countries, fellows are paid an additional flat-rate of 150 euros per month to cover minor project-related costs (books, travel expenses, etc.), and to cover premiums for personal insurance. The stipend is transferred to the fellow's personal bank account by the middle of each month.
Tuition, bench fees and overheads are not reimbursed by the foundation.
The fellowship is intended to cover the living expenses of the recipient. A Boehringer Ingelheim Fonds stipend may therefore not be held while receiving a regular personal income from any other institution or research institute. Any employment or other contracts yielding a regular income must be cancelled upon accepting the MD fellowship. However, an additional fellowship from another institution to cover exclusively tuition fees may be accepted. Please contact the foundation under these circumstances.
Fellowships awarded by the Boehringer Ingelheim Fonds do not constitute any form of employment. In Germany (EStG § 3 No. 44) and in countries that maintain a double-taxation agreement with Germany, fellowships are exempt from tax. A fellowship is not considered to be remuneration as defined by Article 14 of the German Social Law IV and is therefore not liable to social insurance. Provision of laws governing formation of capital, saving premiums and residential building premiums do not apply.
The Boehringer Ingelheim Fonds does not provide any kind of insurance for its fellowship holders. They must insure themselves and their families against any possible costs and consequences caused by illness, accident, personal liability, etc.
In the event of illness, the Boehringer Ingelheim Fonds continues payments for 2 months, after which time assistance would cease. Upon recovery, the fellowship may be extended by the period of absence due to illness.
Fellowship holders are expected to supply reprints of all publications prepared with the foundation`s assistance. In addition, they must present a final report, no later than 2 months after the fellowship ends.
The Boehringer Ingelheim Fonds reserves the right to reclaim any surplus payment or money paid in error. Furthermore, the foundation may cancel the fellowship and demand repayment if the fellowship was obtained under false pretences or not used for its intended purpose, if the obligation to submit the final report is not fulfilled, or for any other sound reason.
To process the fellowship holders' applications and to provide continuous support, the Boehringer Ingelheim Fonds gathers and electronically stores the data submitted by applicants. These data include personal information (name, address, date of birth, nationality, phone numbers and e-mail addresses of the fellowship holders) as well as information on the research project and the support granted.